{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:50:24Z","timestamp":1767135024462,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd011499","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000}}],"reference-count":177,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011499.pub2","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T10:18:02Z","timestamp":1487672282000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Renal denervation for resistant hypertension"],"prefix":"10.1002","volume":"2017","author":[{"given":"Giuseppe","family":"Coppolino","sequence":"first","affiliation":[{"name":"\"Pugliese-Ciaccio\" General Hospital; Nephrology and Dialysis Unit; Viale pio X Catanzaro Catanzaro Italy 88100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pisano","sequence":"additional","affiliation":[{"name":"CNR - Italian National Council of Research; Institute of Clinical Physiology; CNR-IFC Via Vallone Petrara c\/o Ospedali Riuniti Reggio Calabria Italy 89100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rivoli","sequence":"additional","affiliation":[{"name":"University \"Magna Graecia\"; Department of Medical and Surgical Sciences, Nephrology and Dialysis Unit; Viale Europa Catanzaro Italy 88100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Bolignano","sequence":"additional","affiliation":[{"name":"CNR - Italian National Council of Research; Institute of Clinical Physiology; CNR-IFC Via Vallone Petrara c\/o Ospedali Riuniti Reggio Calabria Italy 89100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"issue":"9981","key":"10.1002\/14651858.CD011499.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","article-title":"Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENER-HTN): a multicentre, open-label, randomised controlled trial","volume":"385","author":"Azizi","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/01.hjh.0000467481.97567.70","article-title":"Prevalence and risk factors for refractory hypertension in the DENER-HTN study","volume":"33","author":"Forni","year":"2015","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0003|cit3","unstructured":"NCT01570777 Renal denervation in patients with resistant hypertension (DENER-HTN) clinicaltrials.gov\/ct2\/show\/NCT01570777"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0004|cit4","first-page":"S341","article-title":"DENER-HTN trial: a prospective randomized control trial of the efficacy of renal artery denervation in resistant hypertension","volume":"1","author":"Sapoval","year":"2014","journal-title":"CardioVascular and Interventional Radiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/HYPERTENSIONAHA.115.05283","article-title":"Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension","volume":"65","author":"Desch","year":"2015","journal-title":"Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD011499.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"592-600","DOI":"10.1007\/s00392-015-0955-8","article-title":"Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial","volume":"105","author":"Fengler","year":"2016","journal-title":"Clinical Research in Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0007|cit7","unstructured":"NCT01656096 Renal sympathetic denervation in patients with mild refractory hypertension clinicaltrials.gov\/ct2\/show\/NCT01656096"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0008|cit8","first-page":"771","article-title":"Percutaneous renal denervation (PRD) improves central hemodynamics and arterial stiffness - a pilot study","volume":"33","author":"Franzen","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/HYPERTENSIONAHA.115.06260","article-title":"Effect of catheter-based renal denervation on morning and nocturnal blood pressure: insights from SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan","volume":"66","author":"Kario","year":"2015","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1253\/circj.CJ-15-0150","article-title":"SYMPLICITY HTN-Japan - First randomized controlled trial of catheter-based renal denervation in Asian patients","volume":"79","author":"Kario","year":"2015","journal-title":"Circulation Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/01.hjh.0000467484.20438.39","article-title":"Preferential reduction in morning\/nocturnal hypertension by renal denervation for drug-resistant hypertension: a new ABPM analysis of SYMPLICITY HTN-3 and HTN-Japan","volume":"33 Suppl 1","author":"KarioK","year":"2015","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0012|cit12","unstructured":"NCT01644604 The clinical study of renal denervation by MDT-2211 system in patients with uncontrolled hypertension clinicaltrials.gov\/ct2\/show\/NCT01644604"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0013|cit13","first-page":"718","article-title":"Renal sympathetic denervation is inferior to adjusted drug treatment in patients with true treatment resistant hypertension, a randomized controlled trial","volume":"35","author":"Fadl El Mula","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.114.03246","article-title":"Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension","volume":"63","author":"Fadl Elmula","year":"2014","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"A1306","DOI":"10.1016\/S0735-1097(14)61306-1","article-title":"Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment resistant hypertension, a randomized clinical trial","volume":"1","author":"Fadl Elmula","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0016|cit16","unstructured":"NCT01673516 Effect of renal sympathetic denervation on resistant hypertension and cardiovascular hemodynamic in comparison to intensive medical therapy utilizing impedance cardiography (OsloRDN) clinicaltrials.gov\/ct2\/show\/NCT01673516"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0017|cit17","unstructured":"NCT01560312 Renal denervation in refractory hypertension clinicaltrials.gov\/ct2\/show\/NCT01560312"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/HYPERTENSIONAHA.114.04019","article-title":"Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study","volume":"65","author":"Rosa","year":"2015","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/HYPERTENSIONAHA.115.06526","article-title":"Role of adding spironolactone and renal denervation in true resistant hypertension: one-year outcomes of randomized PRAGUE-15 study","volume":"67","author":"Rosa","year":"2016","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/jhh.2014.3","article-title":"Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?","volume":"28","author":"Rosa","year":"2014","journal-title":"Journal of Human Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/j.crvasa.2014.04.004","article-title":"Catheter-based renal denervation versus intensified medical treatment in patients with resistant hypertension: rationale and design of a multicenter randomized study - PRAGUE-15","volume":"56","author":"Tousek","year":"2014","journal-title":"Cor et Vasa"},{"issue":"126","key":"10.1002\/14651858.CD011499.pub2-BIB0022|cit22","first-page":"A17520","article-title":"Renal sympathetic denervation for the management of chronic hypertension (RELIEF): 40 patient analysis","volume":"1","author":"Ahmed","year":"2012","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0023|cit23","first-page":"S469","article-title":"Renal sympathetic denervation for the management of chronic hypertension (RELIEF): an interim analysis","volume":"1","author":"Ahmed","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0024|cit24","unstructured":"NCT01628172 Renal sympathetic denervation for the management of chronic hypertension (RELIEF) clinicaltrials.gov\/ct2\/show\/NCT01628172 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"B41","DOI":"10.1016\/j.jacc.2015.08.133","article-title":"Renal sympathetic denervation in treatment resistant essential hypertension. A sham-controlled, double-blinded randomized trial (ReSET trial)","volume":"66","author":"Mathiassen","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0026|cit26","unstructured":"NCT01459900 Renal sympathectomy in treatment resistant essential hypertension: a sham controlled randomized trial clinicaltrials.gov\/ct2\/show\/NCT01459900 (first received 2011)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0027|cit27","first-page":"770","article-title":"One-year pooled outcomes following renal sympathetic denervation in patients with resistant hypertension: from the SYMPLICITY HTN-2 trial","volume":"33","author":"Boehm","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0030|cit28","first-page":"2220","article-title":"SYMPLICITY HTN-2: international, multicenter, prospective, randomized, controlled trial of endovascular selective renal sympathetic denervation for the treatment of hypertension","volume":"122","author":"Esler","year":"2010","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0028|cit29","doi-asserted-by":"crossref","first-page":"E1705","DOI":"10.1016\/S0735-1097(12)61706-9","article-title":"Renal sympathetic denervation for treatment of resistant hypertension: One year results from the SYMPLICITY HTN-2 randomized controlled trial","volume":"1)","author":"Esler","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0029|cit30","doi-asserted-by":"crossref","first-page":"E1386","DOI":"10.1016\/S0735-1097(13)61386-8","article-title":"Renal sympathetic denervation for treatment of resistant hypertension: Two-year update from the SYMPLICITY HTN-2 randomized controlled trial","volume":"1)","author":"Esler","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/eurheartj\/ehu209","article-title":"Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36-month results from the SYMPLICITY HTN-2 randomized clinical trial","volume":"35","author":"Esler","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","article-title":"Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the SYMLICITY HTN-2 randomized, controlled trial","volume":"126","author":"Esler","year":"2012","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0033|cit33","first-page":"181","article-title":"Catheter-based renal sympathetic denervation in patients with resistant hypertension: 18-month follow-up of the SYMPLICITY HTN-2 trial","volume":"33","author":"Esler","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"B19","DOI":"10.1016\/j.jacc.2013.08.791","article-title":"Persistent and safe blood pressure lowering effects of renal artery denervation: three-year follow-up from the SYMPLICITY HTN-2 trial","volume":"1","author":"Esler","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"21","key":"10.1002\/14651858.CD011499.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1556\/OH.2014.21M","article-title":"Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the SYMPLICITY HTN-2 randomized, controlled trial","volume":"155","author":"Fischer","year":"2014","journal-title":"Orvosi Hetilap"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011499.pub2-BIB0036|cit36","first-page":"28","article-title":"Long-term follow-up of catheter-based renal denervation in patients with treatment resistant hypertension: the SYMPLICITY HTN-2 trial","volume":"15","author":"Murray","year":"2013","journal-title":"Journal of Clinical Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0037|cit37","unstructured":"NCT00888433 Renal denervation in patients with uncontrolled hypertension (SYMPLICITY HTN-2) clinicaltrials.gov\/ct2\/show\/NCT00888433 (first received 2009)"},{"issue":"9756","key":"10.1002\/14651858.CD011499.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (the SYMPLICITY HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Symplicity HTN-2 Investigators","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0039|cit39","first-page":"158","article-title":"Cardiorespiratory response to exercise after renal sympathetic denervation in resistant hypertension","volume":"125","author":"Ukena","year":"2013","journal-title":"Cardiology (Switzerland)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jacc.2011.05.036","article-title":"Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension","volume":"58","author":"Ukena","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0041|cit41","first-page":"960","article-title":"Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension","volume":"32","author":"Ukena","year":"2011","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2014.05.012","article-title":"Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3","volume":"64","author":"Bakris","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2015.01.037","article-title":"12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial","volume":"65","author":"Bakris","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"B38","DOI":"10.1016\/j.jacc.2015.08.127","article-title":"Long-term (24-month) blood pressure results of catheter-based renal artery denervation: SYMPLICITY HTN-3 randomized controlled trial","volume":"1","author":"Bhatt","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0046|cit45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jvs.2014.05.038","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"60","author":"Bhatt","year":"2014","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0045|cit46","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0047|cit47","first-page":"345","article-title":"Controlled clinical trial on renal denervation in resistant hypertension","volume":"40","author":"Divison","year":"2014","journal-title":"Semergen"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"B119","DOI":"10.1016\/j.jacc.2014.07.455","article-title":"SYMPLICITY HTN-3: outcomes in the African-American and Non-African American populations","volume":"1","author":"Flack","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jash.2015.08.001","article-title":"An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial","volume":"9","author":"Flack","year":"2015","journal-title":"Journal of the American Society of Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","article-title":"Predictors of blood pressure response in the SYMPLICITY HTN-3 trial","volume":"36","author":"Kandzari","year":"2015","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/clc.22008","article-title":"Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 trial","volume":"35","author":"Kandzari","year":"2012","journal-title":"Clinical Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/01.hjh.0000467484.20438.39","article-title":"Preferential reduction in morning\/nocturnal hypertension by renal denervation for drug-resistant hypertension: a new ABPM analysis of SYMPLICITY HTN-3 and HTN-Japan","volume":"33 Suppl 1","author":"Kario","year":"2015","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0053|cit53","first-page":"186","article-title":"Potential reduction in office and nocturnal blood pressure after renal denervation in patients with obstructive sleep apnea: A subgroup analysis of SYMPLICITY HTN-3","volume":"36","author":"Kario","year":"2015","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/HYPERTENSIONAHA.115.06260","article-title":"Effect of catheter-based renal denervation on morning and nocturnal blood pressure: insights from SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan","volume":"66","author":"Kario","year":"2015","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0055|cit55","unstructured":"NCT01418261 Renal denervation in patients with uncontrolled hypertension (SYMPLICITY HTN-3) clinicaltrials.gov\/ct2\/show\/NCT01418261 (first received 2011)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/01.hjh.0000467641.39623.fb","article-title":"Failure of renal denervation in SYMPLICITY HTN-3 is a predictable result of anatomically inadequate operative technique and not the true limitations of the technology","volume":"33 Suppl 1","author":"Pekarskiy","year":"2015","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0057|cit57","unstructured":"NCT01366625 Renal denervation in patients with resistant hypertension and obstructive sleep apnea clinicaltrials.gov\/ct2\/show\/NCT01366625 (first received 2011)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0058|cit58","first-page":"231","article-title":"The impact of renal sympathetic denervation on office and ambulatory blood pressure levels in patients with true resistant hypertension and obstructive sleep apnea: the interim analysis","volume":"35","author":"Warchol","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0059|cit59","first-page":"145","article-title":"Effects of catheter-based renal sympathetic denervation at different segments of the renal artery on resistant hypertension","volume":"20","author":"Xiang","year":"2014","journal-title":"Experimental and Clinical Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3724\/SP.J.1008.2014.00191","article-title":"Effect of ablation sites in catheter-based renal sympathetic denervation on anti-hypertension results in patients with resistant hypertension","volume":"35","author":"Xu","year":"2014","journal-title":"Academic Journal of Second Military Medical University"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jcin.2012.01.027","article-title":"Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension","volume":"5","author":"Ahmed","year":"2012","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/jce.12095","article-title":"Adjunctive renal sympathetic denervation to modify hypertension as upstream therapy in the treatment of atrial fibrillation (H-FIB) study: clinical background and study design","volume":"24","author":"Ahmed","year":"2013","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension","volume":"59","author":"Brandt","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2012.08.959","article-title":"Effects of renal sympathetic denervation on arterial stiffness and central hemodynamics in patients with resistant hypertension","volume":"60","author":"Brandt","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0065|cit65","unstructured":"ChiCTR-ONC-12002901 Transcatheter renal denervation for patients with resistant hypertension www.chictr.org.cn 2012"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0066|cit66","unstructured":"ChiCTR-ONC-13003231 Noninvasive renal sympathetic denervation by high-intensity focused ultrasound (HIFU) in patients with refractory hypertension www.chictr.org.cn 2013"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0067|cit67","unstructured":"ChiCTR-TNC-12002900 A comprehensive assessment of the cardiovascular effects of transcatheter renal sympathetic nerve denervation www.chictr.org.cn 2012"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0068|cit68","unstructured":"NCT01836146 International first-in-human study of the EnligHTN generation 2 system in patients with drug-resistant uncontrolled hypertension (EnligHTN III) clinicaltrials.gov\/ct2\/show\/NCT01836146 (first received 2013)"},{"issue":"S22","key":"10.1002\/14651858.CD011499.pub2-BIB0069|cit69","first-page":"A14747","article-title":"Renal denervation via catheter-based delivery of radiofrequency energy significantly reduces blood pressure in subjects with severe treatment-resistant hypertension: long-term results from the SYMPLICITY-HTN clinical trials","volume":"128","author":"Esler","year":"2013","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.113.01985","article-title":"Effects of renal sympathetic denervation on exercise blood pressure, heart rate, and capacity in patients with resistant hypertension","volume":"63","author":"Ewen","year":"2014","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/HYPERTENSIONAHA.113.01452","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure","volume":"62","author":"Fadl Elmula","year":"2013","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/HYPERTENSIONAHA.114.04823","article-title":"Blood pressure responses to renal denervation precede and are independent of the sympathetic and baroreflex effects","volume":"65","author":"Grassi","year":"2015","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1097\/HJH.0b013e3283622e58","article-title":"Renal nerve ablation reduces augmentation index in patients with resistant hypertension","volume":"31","author":"Hering","year":"2013","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ahj.2015.08.021","article-title":"The SPYRAL-HTN global clinical trial program: rationale and design for studies of renal denervation in the absence (SPYRAL-HTN OFF-MED) and presence (SPYRAL-HTN ON-MED) of antihypertensive medications","volume":"171","author":"Kandzari","year":"2016","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0075|cit75","first-page":"179","article-title":"The effect of renal arteries sympathectomy on refractory hypertension","volume":"71","author":"Karbasi-Afshar","year":"2013","journal-title":"Tehran University Medical Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0076|cit76","first-page":"S50","article-title":"Pooled 3-year SYMPLICITY HTN-1 and SYMPLICITY HTN-2 results and diabetes subgroup analysis","volume":"1","author":"Katholi","year":"2014","journal-title":"JACC: Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08037051.2014.916896","article-title":"Renal denervation in treatment-resistant hypertension: Oslo RDN, SYMPLICITY HTN-3 and INSPiRED randomized trials","volume":"23","author":"Kjeldsen","year":"2014","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0078|cit78","first-page":"622-9 [Erratum","article-title":"Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the SYMPLICITY HTN-1 study","volume":"383","author":"Krum","year":"2014","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0079|cit79","first-page":"36","article-title":"Effect of renal sympathetic denervation on glucosmetabolism in patients with resistant hypertension","volume":"52","author":"Mahfoud","year":"2011","journal-title":"Internist"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study","volume":"123","author":"Mahfoud","year":"2011","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.112.193870","article-title":"Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension","volume":"60","author":"Mahfoud","year":"2012","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/eurheartj\/ehu093","article-title":"Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial","volume":"35","author":"Mahfoud","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0083|cit83","unstructured":"NCT01117025 Combined treatment of resistant hypertension and atrial fibrillation clinicaltrials.gov\/ct2\/show\/NCT01117025 (first received 2010)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0084|cit84","unstructured":"NCT01465724 Renal sympathetic denervation for treatment of metabolic syndrome associated hypertension (Metabolic Syndrome study) clinicaltrials.gov\/ct2\/show\/NCT01465724 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0085|cit85","unstructured":"NCT01583881 Renal denervation in patients with heart failure with normal LV ejection fraction clinicaltrials.gov\/ct2\/show\/NCT01583881 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0086|cit86","unstructured":"NCT01631370 The effects of renal sympathetic denervation on insulin sensitivity in patients with resistant essential hypertension clinicaltrials.gov\/ct2\/show\/NCT01631370 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0087|cit87","unstructured":"NCT01635998 Adjunctive renal sympathetic denervation to modify hypertension as upstream therapy in the treatment of atrial fibrillation clinicaltrials.gov\/ct2\/show\/NCT01635998 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0088|cit88","unstructured":"NCT01687725 Renal denervation in treatment resistant hypertension clinicaltrials.gov\/ct2\/show\/NCT01687725 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0089|cit89","unstructured":"NCT01733901 Renal sympathetic denervation as secondary prevention for patients after percutaneous coronary intervention clinicaltrials.gov\/ct2\/show\/NCT01733901 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0090|cit90","unstructured":"NCT01814111 Safety and effectiveness study of percutaneous catheter-based sympathetic denervation of the renal arteries in patients with hypertension and paroxysmal atrial fibrillation clinicaltrials.gov\/ct2\/show\/NCT01814111 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0091|cit91","unstructured":"NCT01848314 The effect of renal denervation on renal flow in humans clinicaltrials.gov\/ct2\/show\/NCT01848314 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0092|cit92","unstructured":"NCT01873352 Renal artery denervation in addition to catheter ablation to eliminate atrial fibrillation clinicaltrials.gov\/ct2\/show\/NCT01873352 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0093|cit93","unstructured":"NCT01888315 Influence of catheter-based renal denervation in diseases with increased sympathetic activity clinicaltrials.gov\/ct2\/show\/NCT01888315 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0094|cit94","unstructured":"NCT01897545 The role of renal denervation in improving outcomes of catheter ablation in patients with atrial fibrillation and arterial hypertension clinicaltrials.gov\/ct2\/show\/NCT01897545 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0095|cit95","unstructured":"NCT01901549 Renal denervation in patients after acute coronary syndrome clinicaltrials.gov\/ct2\/show\/NCT01901549 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0096|cit96","unstructured":"NCT01907828 A feasibility study to evaluate the effect of concomitant renal denervation and cardiac ablation on AF recurrence clinicaltrials.gov\/ct2\/show\/NCT01907828 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0097|cit97","unstructured":"NCT01932450 Radiofrequency ablation for ADPKD blood pressure and disease progression control clinicaltrials.gov\/ct2\/show\/NCT01932450 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0098|cit98","unstructured":"NCT02016573 Renal denervation for uncontrolled hypertension clinicaltrials.gov\/ct2\/show\/NCT02016573 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0099|cit99","unstructured":"NCT02057224 Metabolic and cardiovascular effects of renal denervation clinicaltrials.gov\/ct2\/show\/NCT02057224 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0100|cit100","unstructured":"NCT02115100 Treatment of atrial fibrillation in patients by pulmonary vein isolation, renal artery denervation or both clinicaltrials.gov\/ct2\/show\/NCT02115100 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0101|cit101","unstructured":"NCT02115230 Transcatheter renal denervation in heart failure with normal left ventricular ejection fraction - a safety and efficacy study of irrigated radiofrequency catheter clinicaltrials.gov\/ct2\/show\/NCT02115230 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0102|cit102","unstructured":"NCT02155790 The Peregrine study: a safety and performance study of renal denervation clinicaltrials.gov\/ct2\/show\/NCT02155790 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0103|cit103","unstructured":"NCT02164435 Effects of renal sympathetic denervation on the cardiac and renal functions in patients with drug-resistant hypertension through MRI evaluation (RDN) clinicaltrials.gov\/ct2\/show\/NCT02164435 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0104|cit104","unstructured":"NCT02272920 PCI and renal denervation in hypertensive patients with acute coronary syndromes clinicaltrials.gov\/ct2\/show\/NCT02272920 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0105|cit105","unstructured":"NCT02559882 Testing effectiveness of renal denervation in patients with therapy-resistant hypertension clinicaltrials.gov\/ct2\/show\/NCT02559882 (first received 2015)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0106|cit106","first-page":"382","article-title":"Renal denervation and pulmonary vein isolation in patients with drug resistant hypertension and symptomatic atrial fibrillation","volume":"33","author":"Pokushalov","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0107|cit107","first-page":"S172","article-title":"Renal denervation and pulmonary vein isolation in patients with drug resistant hypertension and symptomatic atrial fibrillation","volume":"1","author":"Pokushalov","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jacc.2012.05.036","article-title":"A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension","volume":"60","author":"Pokushalov","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"A280","DOI":"10.1016\/S0735-1097(14)60280-1","article-title":"The role of renal denervation in improving outcomes of catheter ablation in patients with atrial fibrillation and moderate resistant or resistant hypertension","volume":"1","author":"Pokushalov","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0110|cit110","first-page":"434","article-title":"Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience","volume":"35","author":"Pokushalov","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.hrthm.2014.03.055","article-title":"Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience","volume":"11","author":"Pokushalov","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0112|cit112","unstructured":"NCT02649426 A study of the ReCor Medical Paradise system in clinical hypertension (RADIANCE-HTN) clinicaltrials.gov\/ct2\/show\/NCT02649426 (first received 2016)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0113|cit113","unstructured":"NCT01520506 Rapid renal sympathetic denervation for resistant hypertension (RAPID) clinicaltrials.gov\/ct2\/show\/NCT01520506 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0114|cit114","unstructured":"NCT01355055 Sympathetic activity and renal denervation (ReD) clinicaltrials.gov\/ct2\/show\/NCT01355055 (first received 2011)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0115|cit115","unstructured":"NCT02392351 Renal denervation using the Vessix Renal Denervation system for the treatment of hypertension (REDUCE HTN:REINFORCE) clinicaltrials.gov\/ct2\/show\/NCT02392351 (first received 2015)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0116|cit116","unstructured":"NTR4384 Feasibility of electrical mapping and stimulation of renal arteries in patients undergoing renal denervation Netherlands Trial Register. http:\/\/www.trialregister.nl 2014"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0117|cit117","unstructured":"NCT02642445 Renal sympathetic denervation from the adventitia on hypertension (RSDAH) clinicaltrials.gov\/ct2\/show\/NCT02642445 (first received 2015)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0004563214543765","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"51","author":"Shipman","year":"2014","journal-title":"Annals of Clinical Biochemistry"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0119|cit119","unstructured":"NCT02439749 Global clinical study of renal denervation with the SYMPLICITY SPYRAL\u2122 multi-electrode renal denervation system in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED) clinicaltrials.gov\/ct2\/show\/NCT02439749 2015"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0120|cit120","unstructured":"NCT02439775 Global clinical study of renal denervation with the SYMPLICITY SPYRAL\u2122 multi-electrode renal denervation system in patients with uncontrolled hypertension on standard medical therapy (SPYRAL HTN-ON MED) clinicaltrials.gov\/ct2\/show\/NCT02439775 2015"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months","volume":"57","author":"SYMPLICITY HTN Investigators","year":"2011","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0122|cit122","unstructured":"NCT02064764 Renal nerve denervation in patients with hypertension and paroxysmal and persistent atrial fibrillation (SYMPLICITY AF) clinicaltrials.gov\/ct2\/show\/NCT02064764 2014"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0123|cit123","unstructured":"UMIN000012020 Study of renal sympathetic denervation with radiofrequency ablation catheter for resistant essential hypertension UMIN Clinical Trial Registry http:\/\/umin.ac.jp 2013"},{"issue":"S1","key":"10.1002\/14651858.CD011499.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"T7","DOI":"10.1186\/1532-429X-17-S1-T7","article-title":"The utility of magnetic resonance imaging in a trial to assess the effect of renal denervation in heart failure with preserved ejection fraction","volume":"17","author":"Wage","year":"2015","journal-title":"Journal of Cardiovascular Magnetic Resonance"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0125|cit125","unstructured":"NCT02029885 Sham controlled study of renal denervation for subjects with uncontrolled hypertension (WAVE IV) clinicaltrials.gov\/ct2\/show\/NCT02029885 2014"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0126|cit126","unstructured":"NCT02480517 Wave VI feasibility study: Phase II randomized sham controlled study of renal denervation for untreated Stage I and II hypertension clinicaltrials.gov\/ct2\/show\/NCT02480517 2015"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/HYPERTENSIONAHA.111.173799","article-title":"Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea","volume":"58","author":"Witkowski","year":"2011","journal-title":"Hypertension"},{"issue":"S22","key":"10.1002\/14651858.CD011499.pub2-BIB0128|cit128","first-page":"A17684","article-title":"Preliminary effects of renal sympathetic denervation with saline irrigated catheter on systolic function in patients with heart failure - a feasibility report from the swan-HF pilot study","volume":"128","author":"Yin","year":"2013","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/jch.12367","article-title":"The effects of catheter-based radiofrequency renal denervation on renal function and renal artery structure in patients with resistant hypertension","volume":"16","author":"Zhang","year":"2014","journal-title":"Journal of Clinical Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0130|cit130","unstructured":"NCT01874470 Renal denervation by Allegro system in patients with resistant hypertension clinicaltrials.gov\/ct2\/show\/NCT01874470 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0131|cit131","unstructured":"NCT02039492 Sympathetic renal denervation versus increment of pharmacological treatment in resistant arterial hypertension clinicaltrials.gov\/ct2\/show\/NCT02039492 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0132|cit132","unstructured":"NCT01522430 Denervation of renal sympathetic activity and hypertension study clinicaltrials.gov\/ct2\/show\/NCT01522430 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0133|cit133","unstructured":"NCT01903187 Multi-center, randomized, single-blind, sham controlled clinical investigation of renal denervation for uncontrolled hypertension clinicaltrials.gov\/ct2\/show\/NCT01903187 (first received 2013"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0134|cit134","unstructured":"NCT02102126 Effect of renal denervation on arterial stiffness and haemodynamics in patients with uncontrolled hypertension (ENSURE) clinicaltrials.gov\/ct2\/show\/NCT02102126 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/08037051.2014.899297","article-title":"Rationale and design of the investigator-steered project on intravascular renal denervation for management of drug-resistant hypertension (INSPiRED) trial","volume":"23","author":"Jin","year":"2014","journal-title":"Blood Pressure"},{"issue":"S4","key":"10.1002\/14651858.CD011499.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jash.2014.03.165","article-title":"Rationale and design of the investigator-steered project on intravascular renal denervation for management of drug-resistant hypertension (INSPiRED) trial","volume":"8","author":"Jin","year":"2014","journal-title":"Journal of the American Society of Hypertension"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0137|cit137","unstructured":"NCT01505010 Investigator-steered project on intravascular renal denervation for management of drug-resistant hypertension (INSPIRED) clinicaltrials.gov\/ct2\/show\/NCT01505010 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0138|cit138","unstructured":"NCT02002585 Renal protection using sympathetic denervation in patients with chronic kidney disease (Kidney protection study - KPS Study) clinicaltrials.gov\/ct2\/show\/NCT02002585 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0139|cit139","unstructured":"NCT01848275 Full length versus proximal renal arteries ablation clinicaltrials.gov\/ct2\/show\/NCT01848275 (first received 2011)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0140|cit140","unstructured":"NCT01918111 Effects of renal denervation for resistant hypertension on exercise diastolic function and regression of atherosclerosis and the evaluation of new methods predicting a successful renal sympathetic denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDICT trial From RENEWAL RDN Registry) clinicaltrials.gov\/ct2\/show\/NCT01918111 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0141|cit141","unstructured":"NCT01968785 Renal denervation in patients with uncontrolled blood pressure clinicaltrials.gov\/ct2\/show\/NCT01968785 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0142|cit142","unstructured":"NCT02021019 Renal denervation to improve outcomes in patients with end-stage renal disease clinicaltrials.gov\/ct2\/show\/NCT02021019 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0143|cit143","unstructured":"NCT02346045 Effect of renal denervation in end stage renal disease with resistant hypertension clinicaltrials.gov\/ct2\/show\/NCT02346045 (first received 2014)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0144|cit144","unstructured":"NCT02444442 The Australian SHAM controlled clinical trial of renal denervation in patients with resistant hypertension (AUSHAM RDN-01) clinicaltrials.gov\/ct2\/show\/NCT02444442 (first received 2015)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0145|cit145","unstructured":"NCT02608632 High frequency guided renal artery denervation for improving outcome of renal ablation procedure clinicaltrials.gov\/ct2\/show\/NCT02608632 (first received 2015)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0146|cit146","unstructured":"NCT02667912 Distal renal denervation clinicaltrials.gov\/ct2\/show\/NCT02667912 (first received 2016)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0147|cit147","unstructured":"NTR3444 Endovascular renal sympathetic denervation versus spironolactone in treatment-resistant hypertension: a randomized, multicentric study (RRSS trial) www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=3444 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0148|cit148","unstructured":"NCT01895140 A study of renal denervation in patients with treatment resistant hypertension clinicaltrials.gov\/ct2\/show\/NCT01895140 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0149|cit149","unstructured":"NCT01939392 Rapid renal sympathetic denervation for resistant hypertension using the OneShot renal denervation system II (RAPID II) clinicaltrials.gov\/ct2\/show\/NCT01939392 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0150|cit150","unstructured":"NCT01865240 Renal denervation for resistant hypertension clinicaltrials.gov\/ct2\/show\/NCT01865240 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0151|cit151","unstructured":"NCT01617551 Effect of renal denervation on no-mediated regulation of salt and water excretion, vasoactive hormones and tubular transport proteins in patients with resistant hypertension (RENO) clinicaltrials.gov\/ct2\/show\/NCT01617551 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0152|cit152","unstructured":"NCT01785732 Renal sympathetic denervation and insulin sensitivity (RENSYMPIS study) clinicaltrials.gov\/ct2\/show\/NCT01785732 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0153|cit153","unstructured":"NCT01762488 Renal denervation in treatment resistant hypertension, a double-blind randomized controlled trial (ReSET-2) clinicaltrials.gov\/ct2\/show\/NCT01762488 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0154|cit154","unstructured":"NCT01737138 Safety and effectiveness study of percutaneous catheter-based renal sympathetic denervation in patients with chronic kidney disease and resistant hypertension clinicaltrials.gov\/ct2\/show\/NCT01737138 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0155|cit155","unstructured":"NCT01713270 Safety and effectiveness study of percutaneous catheter-based renal sympathetic denervation in patients with drug-resistant hypertension and symptomatic atrial fibrillation clinicaltrials.gov\/ct2\/show\/NCT01713270 (first received 2012)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1745-6215-14-168","article-title":"Renal sympathetic denervation versus antiarrhythmic drugs for drug-resistant hypertension and symptomatic atrial fibrillation (RSDforAF) trial: study protocol for a randomized controlled trial","volume":"14","author":"Qiu","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0157|cit157","unstructured":"NCT01850901 Renal sympathetic denervation as a new treatment for therapy resistant hypertension - a multicenter randomized controlled trial clinicaltrials.gov\/ct2\/show\/NCT01850901 (first received 2013)"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ahj.2013.11.010","article-title":"The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: rationale and design of the SYMPATHY trial","volume":"167","author":"Vink","year":"2014","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0159|cit159","unstructured":"NCT01972139 Renal denervation in patients with uncontrolled hypertension - SYMPLICITY HTN-4 clinicaltrials.gov\/ct2\/show\/NCT01972139 (first received 2013)"},{"issue":"5","key":"10.1002\/14651858.CD011499.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1113\/expphysiol.2014.079871","article-title":"Reinnervation following catheter-based radiofrequency renal denervation","volume":"100","author":"Booth","year":"2015","journal-title":"Experimental Physiology"},{"issue":"25","key":"10.1002\/14651858.CD011499.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD011499.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2013.04.010","article-title":"Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis","volume":"16","author":"Davis","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"285","key":"10.1002\/14651858.CD011499.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"285fs18","DOI":"10.1126\/scitranslmed.aaa5457","article-title":"Renal denervation: not as easy as it looks","volume":"7","author":"Esler","year":"2015","journal-title":"Science Translational Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011499.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/08037051.2015.1058595","article-title":"Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension","volume":"24","author":"Fadl Elmula","year":"2015","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0165|cit165","unstructured":"Hamilton: McMaster University (developed by Evidence Prime, Inc.) Gradepro GDT. GRADEpro Guideline Development Tool [www.guidelinedevelopment.org] 2015"},{"issue":"7650","key":"10.1002\/14651858.CD011499.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7414","key":"10.1002\/14651858.CD011499.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0168|cit168","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD011499.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/clc.22071","article-title":"Renal denervation: a potential new treatment for severe hypertension","volume":"36","author":"Huan","year":"2013","journal-title":"Clinical Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD011499.pub2-BIB0170|cit170","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/jhh.2013.140","article-title":"Apparent and true resistant hypertension: definition, prevalence and outcomes","volume":"28","author":"Judd","year":"2014","journal-title":"Journal of Human Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD011499.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","article-title":"Predictors of blood pressure response in the SYMPLICITY HTN-3 trial","volume":"36","author":"Kandzari","year":"2015","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-051812-145353","article-title":"Renal sympathetic denervation for the treatment of refractory hypertension","volume":"65","author":"Leong","year":"2014","journal-title":"Annual Review of Medicine"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"e7473","DOI":"10.1136\/bmj.e7473","article-title":"Resistant hypertension","volume":"345","author":"Myat","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD011499.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"e000375","DOI":"10.1161\/JAHA.113.000375","article-title":"Renal denervation prevents stroke and brain injury via attenuation of oxidative stress in hypertensive rats","volume":"2","author":"Nakagawa","year":"2013","journal-title":"Journal of the American Heart Association"},{"issue":"4","key":"10.1002\/14651858.CD011499.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"e000197","DOI":"10.1161\/JAHA.113.000197","article-title":"Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome","volume":"2","author":"Katayama","year":"2013","journal-title":"Journal of the American Heart Association"},{"key":"10.1002\/14651858.CD011499.pub2-BIB0176|cit176","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"7","key":"10.1002\/14651858.CD011499.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.03.059","article-title":"Anatomic assessment of sympathetic peri-arterial renal nerves in man","volume":"64","author":"Sakakura","year":"2014","journal-title":"Journal of the American College of Cardiology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011499.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011499.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T03:27:07Z","timestamp":1632108427000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011499.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":177,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011499.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}